Search Results - "FULLER, Donald"

Health-Related Quality of Life After Stereotactic Body Radiation Therapy for Localized Prostate Cancer: Results From a Multi-institutional Consortium of Prospective Trials by King, Christopher R., PhD, MD, Collins, Sean, MD, Fuller, Donald, MD, Wang, Pin-Chieh, PhD, Kupelian, Patrick, MD, Steinberg, Michael, MD, Katz, Alan, MD, JD

“…Purpose To evaluate the early and late health-related quality of life (QOL) outcomes among prostate cancer patients following stereotactic body radiation…”
Get full text

Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials by King, Christopher R, Freeman, Debra, Kaplan, Irving, Fuller, Donald, Bolzicco, Giampaolo, Collins, Sean, Meier, Robert, Wang, Jason, Kupelian, Patrick, Steinberg, Michael, Katz, Alan

“…Abstract Purpose The effectiveness of stereotactic body radiotherapy (SBRT) for localized prostate cancer is tested. Methods and materials A total of 1100…”
Get full text

Prostate Stereotactic Body Radiation Therapy: An Overview of Toxicity and Dose Response by Wang, Kyle, Mavroidis, Panayiotis, Royce, Trevor J., Falchook, Aaron D., Collins, Sean P., Sapareto, Stephen, Sheets, Nathan C., Fuller, Donald B., El Naqa, Issam, Yorke, Ellen, Grimm, Jimm, Jackson, Andrew, Chen, Ronald C.

“…Ultrahypofractionationed radiation therapy for prostate cancer is increasingly studied and adopted. The American Association of Physicists in Medicine Working…”
Get full text

Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus by Jereczek-Fossa, Barbara A., Marvaso, Giulia, Zaffaroni, Mattia, Gugliandolo, Simone Giovanni, Zerini, Dario, Corso, Federica, Gandini, Sara, Alongi, Filippo, Bossi, Alberto, Cornford, Philip, De Bari, Berardino, Fonteyne, Valérie, Hoskin, Peter, Pieters, Bradley R., Tree, Alison C., Arcangeli, Stefano, Fuller, Donald B., Franzese, Ciro, Hannoun-Levi, Jean-Michel, Janoray, Guillaume, Kerkmeijer, Linda, Kwok, Young, Livi, Lorenzo, Loi, Mauro, Miralbell, Raymond, Pasquier, David, Pinkawa, Michael, Scher, Nathaliel, Scorsetti, Marta, Shelan, Mohamed, Toledano, Alain, van As, Nicholas, Vavassori, Andrea, Zilli, Thomas, Pepa, Matteo, Ost, Piet

“…•Between 30% and 47% of PCa patients are at risk of intraprostatic recurrence.•ADT, the standard of care, represents a serious burden in terms of QoL.•Purpose…”
Get full text

Regarding relative toxicities of stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer by Fuller, Donald B

Get full text

Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer by Kishan, Amar U, Dang, Audrey, Katz, Alan J, Mantz, Constantine A, Collins, Sean P, Aghdam, Nima, Chu, Fang-I, Kaplan, Irving D, Appelbaum, Limor, Fuller, Donald B, Meier, Robert M, Loblaw, D Andrew, Cheung, Patrick, Pham, Huong T, Shaverdian, Narek, Jiang, Naomi, Yuan, Ye, Bagshaw, Hilary, Prionas, Nicolas, Buyyounouski, Mark K, Spratt, Daniel E, Linson, Patrick W, Hong, Robert L, Nickols, Nicholas G, Steinberg, Michael L, Kupelian, Patrick A, King, Christopher R

“…Stereotactic body radiotherapy harnesses improvements in technology to allow the completion of a course of external beam radiotherapy treatment for prostate…”
Get full text

Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients by van Dams, Ritchell, Jiang, Naomi Y., Fuller, Donald B., Loblaw, Andrew, Jiang, Tommy, Katz, Alan J., Collins, Sean P., Aghdam, Nima, Suy, Simeng, Stephans, Kevin L., Yuan, Ye, Nickols, Nicholas G., Murthy, Vedang, Telkhade, Tejshri P., Kupelian, Patrick A., Steinberg, Michael L., Romero, Tahmineh, Kishan, Amar U.

“…To explore the efficacy and toxicity of stereotactic body radiation therapy (SBRT) in high-risk prostate cancer (HRPCa) in a consortium of 7 institutional…”
Get full text

Tumor Control Probability Modeling and Systematic Review of the Literature of Stereotactic Body Radiation Therapy for Prostate Cancer by Royce, Trevor J., Mavroidis, Panayiotis, Wang, Kyle, Falchook, Aaron D., Sheets, Nathan C., Fuller, Donald B., Collins, Sean P., El Naqa, Issam, Song, Daniel Y., Ding, George X., Nahum, Alan E., Jackson, Andrew, Grimm, Jimm, Yorke, Ellen, Chen, Ronald C.

“…Dose escalation improves localized prostate cancer disease control, and moderately hypofractionated external beam radiation is noninferior to conventional…”
Get full text

Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations by Fuller, Donald B, Naitoh, John, Lee, Charles, Hardy, Steven, Jin, Haoran

“…We tested our ability to approximate the dose (38 Gy), fractionation (four fractions), and distribution of high-dose-rate (HDR) brachytherapy for prostate…”
Get full text

Opinion: revisiting the means to select and transmit of the AAC model by Fuller, Donald R, Pampoulou, Eliada

“…PurposeThis paper, a theoretical article, aims to revisit the augmentative and alternative communication (AAC) communication model and its transmission…”
Get full text

Introduction of a new AAC symbol classification system: the multidimensional quaternary symbol continuum (MQSC) by Pampoulou, Eliada, Fuller, Donald R

“…PurposeWhen the augmentative and alternative communication (ACC) model (Lloyd et al., 1990) was proposed, these components of symbols were not considered, nor…”
Get full text

Patient and Dosimetric Predictors of Genitourinary and Bowel Quality of Life After Prostate SBRT: Secondary Analysis of a Multi-institutional Trial by Wang, Kyle, Chen, Ronald C., Kane, Brent L., Medbery, Clinton A., Underhill, Kelly J., Gray, James R., Peddada, Anuj V., Fuller, Donald B.

“…Stereotactic body radiation therapy (SBRT) is an emerging option for localized prostate cancer. However, there are no standard dosimetric guidelines, and…”
Get full text

Virtual HDRSM CyberKnife Treatment for Localized Prostatic Carcinoma: Dosimetry Comparison With HDR Brachytherapy and Preliminary Clinical Observations by Fuller, Donald B., M.D, Naitoh, John, M.D, Lee, Charles, Ph.D, Hardy, Steven, C.M.D, Jin, Haoran, Ph.D

“…Background We tested our ability to approximate the dose (38 Gy), fractionation (four fractions), and distribution of high-dose-rate (HDR) brachytherapy for…”
Get full text

Exploring AAC graphic symbol choices: a preliminary study by Pampoulou, Eliada, Fuller, Donald R

“…Purpose Graphic symbols have been used widely in the field of augmentative and alternative communication (AAC). The advancement of technology in recent years…”
Get full text

High Dose “HDR-Like” Prostate SBRT: PSA 10-Year Results From a Mature, Multi-Institutional Clinical Trial by Fuller, Donald B., Crabtree, Tami, Kane, Brent L., Medbery, Clinton A., Pfeffer, Robert, Gray, James R., Peddada, Anuj, Royce, Trevor J., Chen, Ronald C.

“…Purpose/ObjectivesAlthough ample intermediate-term prostate stereotactic body radiotherapy (SBRT) outcomes have been reported, 10-year results remain…”
Get full text

Editorial: The Evolving Landscape of Stereotactic Body Radiation Therapy for the Management of Prostate Cancer by Blacksburg, Seth R, Fuller, Donald B, Haas, Jonathan A

Get full text

Dose–response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control by Levin-Epstein, Rebecca G., Jiang, Naomi Y., Wang, Xiaoyan, Upadhyaya, Shrinivasa K., Collins, Sean P., Suy, Simeng, Aghdam, Nima, Mantz, Constantine, Katz, Alan J., Miszczyk, Leszek, Napieralska, Aleksandra, Namysl-Kaletka, Agnieszka, Prionas, Nicholas, Bagshaw, Hilary, Buyyounouski, Mark K., Cao, Minsong, Agazaryan, Nzhde, Dang, Audrey, Yuan, Ye, Kupelian, Patrick A., Zaorsky, Nicholas G., Spratt, Daniel E., Mohamad, Osama, Feng, Felix Y., Mahal, Brandon A., Boutros, Paul C., Kishan, Arun U., Juarez, Jesus, Shabsovich, David, Jiang, Tommy, Kahlon, Sartajdeep, Patel, Ankur, Patel, Jay, Nickols, Nicholas G., Steinberg, Michael L., Fuller, Donald B., Kishan, Amar U.

“…•Dose-escalation was associated with greater prostate ablation and PSA decay.•All dose groups in our study achieved median nPSAs of ≤0.2 ng/mL.•Dose-escalation…”
Get full text

Testosterone Levels and Sexual Quality of Life After Stereotactic Body Radiation Therapy for Prostate Cancer: A Multi-Institutional Analysis of Prospective Trials by Yuan, Ye, Aghdam, Nima, King, Christopher R., Fuller, Donald B., Weng, Julius, Chu, Fang-I., Mardirossian, George, Patel, Ankur, Nickols, Nicholas G., Kupelian, Patrick A., Steinberg, Michael L., Collins, Sean P., Kishan, Amar U.

“…The impact of higher scatter doses per fraction on testicular function and quality of life after prostate stereotactic body radiation therapy (SBRT) is poorly…”
Get full text

High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: Preliminary prostate-specific antigen response, disease-free survival, and toxicity assessment by Fuller, Donald B., Wurzer, James, Shirazi, Reza, Bridge, Stephen S., Law, Jonathan, Mardirossian, George

“…Patients with locally recurrent adenocarcinoma of the prostate following radiation therapy (RT) present a challenging problem. We prospectively evaluated the…”
Get full text

Phase 2 Multicenter Trial of Heterogeneous-dosing Stereotactic Body Radiotherapy for Low- and Intermediate-risk Prostate Cancer: 5-year Outcomes by Fuller, Donald B., Falchook, Aaron D., Crabtree, Tami, Kane, Brent L., Medbery, Clinton A., Underhill, Kelly, Gray, James R., Peddada, Anuj, Chen, Ronald C.

“…Stereotactic body radiation therapy is an emerging treatment for prostate cancer (PC), with potential biological and oncologic advantages. A well-established…”
Get full text